18F-FET PET影像组学预测接受放化疗的胶质母细胞瘤患者生存
该研究分析了37例接受放化疗的胶质母细胞瘤(WHO 4级)患者,从治疗前18F-FET PET图像提取影像组学特征,经主成分分析筛选变量,用随机森林算法在25例患者中优化并在12例不同扫描仪采集的图像中测试。结果显示,肿瘤与背景比值(TBR)1.4和1.6时的18F-FET-PET体积长轴长度与生存概率降低显著相关,PTV区域影像组学特征在独立测试中分类和回归准确率均为76%。作者认为治疗前18F-FET PET可为胶质母细胞瘤患者生存预测提供相关信息。
要点
- 治疗前18F-FET PET影像组学特征可预测胶质母细胞瘤患者生存。
- TBR 1.4和1.6时体积长轴长度与生存概率降低显著相关。
- PTV区域影像组学特征在独立测试中分类和回归准确率均为76%。
核心结论
- 治疗前18F-FET PET可为胶质母细胞瘤患者生存预测提供相关信息。
- 基于初步分析,PTV区域影像组学特征可被视为生存预测的稳健数据集。
研究设计与样本
- 研究纳入37例接受放化疗的胶质母细胞瘤(WHO 4级)患者,从治疗前18F-FET PET图像提取影像组学特征,采用固定箱宽进行强度重采样,经主成分分析筛选变量。
- 随机森林分类和预测算法在初始25例患者中优化,并在包括额外12例不同扫描仪采集图像的不同场景中测试预测结果的可重复性。
主要发现
- 一阶强度变异和形状特征在生存预测最重要的影像组学特征选择中占主导地位。
- TBR 1.4和1.6时18F-FET-PET体积的长轴长度与生存概率降低显著相关。
- PTV区域的其他影像组学特征被确定为潜在生存预测因子,在独立测试中分类和回归准确率均为76%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. 18F-Fluorethyltyrosine positron emission tomography (18F-FET PET) provides important diagnostic and grading information for brain tumors, but data on its use in survival prediction is scarce. In this study, we aim at investigating survival prediction based on multiple radiomic features in glioblastoma patients undergoing radio(chemo)therapy. METHODS: A dataset of 37 patients with glioblastoma (WHO grade 4) receiving radio(chemo)therapy was analyzed. Radiomic features were extracted from pre-treatment 18F-FET PET images, following intensity rebinning with a fixed bin width. Principal component analysis (PCA) was applied for variable selection, aiming at the identification of the most relevant features in survival prediction. Random forest classification and prediction algorithms were optimized on an initial set of 25 patients. Testing of the implemented algorithms was carried out in different scenarios, which included additional 12 patients whose images were acquired with a different scanner to check the reproducibility in prediction results. RESULTS: First order intensity variations and shape features were predominant in the selection of most important radiomic signatures for survival prediction in the available dataset. The major axis length of the 18F-FET-PET volume at tumor to background ratio (TBR) 1.4 and 1.6 correlated significantly with reduced probability of survival. Additional radiomic features were identified as potential survival predictors in the PTV region, showing 76% accuracy in independent testing for both classification and regression. CONCLUSIONS: 18F-FET PET prior to radiation provides relevant information for survival prediction in glioblastoma patients. Based on our preliminary analysis, radiomic features in the PTV can be considered a robust dataset for survival prediction.
引用
- Wiltgen T, Fleischmann DF, Kaiser L, et al. 18F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy. Radiat Oncol. 2022. PMID: 36461120. doi:10.1186/s13014-022-02164-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。